Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Evans

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Viruses|November 23, 2018
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody AssaysYíngyún Caì, Masaharu Iwasaki, Brett F Beitzel, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
The Journal of Infectious Diseases|July 9, 2018
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus DiseaseLisa Evans DeWald, Julie Dyall, Jennifer M Sword, et al.
Nurse Education Today|February 21, 2018
The educational impact of web-based and face-to-face patient deterioration simulation programs: An interventional trialCatherine Chung, Simon J Cooper, Robyn P Cant, et al.
Plos One|March 23, 2018
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugsElena Postnikova, Yu Cong, Lisa Evans DeWald, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
The Journal of Infectious Diseases|July 18, 2018
In Vitro and In Vivo Activity of Amiodarone Against Ebola VirusJulie Dyall, Joshua C Johnson, Brit J Hart, et al.
Scientific Reports|December 29, 2019
In Vivo Activity of Amodiaquine against Ebola Virus InfectionLisa Evans DeWald, Joshua C Johnson, Dawn M Gerhardt, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Viruses|November 23, 2018
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody AssaysYíngyún Caì, Masaharu Iwasaki, Brett F Beitzel, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
The Journal of Infectious Diseases|July 9, 2018
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus DiseaseLisa Evans DeWald, Julie Dyall, Jennifer M Sword, et al.
Nurse Education Today|February 21, 2018
The educational impact of web-based and face-to-face patient deterioration simulation programs: An interventional trialCatherine Chung, Simon J Cooper, Robyn P Cant, et al.
Plos One|March 23, 2018
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugsElena Postnikova, Yu Cong, Lisa Evans DeWald, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
The Journal of Infectious Diseases|July 18, 2018
In Vitro and In Vivo Activity of Amiodarone Against Ebola VirusJulie Dyall, Joshua C Johnson, Brit J Hart, et al.
Scientific Reports|December 29, 2019
In Vivo Activity of Amodiaquine against Ebola Virus InfectionLisa Evans DeWald, Joshua C Johnson, Dawn M Gerhardt, et al.
Pageof 6